Successful treatment of Netherton's syndrome with topical calcipotriol

European Journal of Dermatology

Volumn 14, Issue 2, 2004, Pages 115-117

  Godic, Aleksandar ^a   Dragos, Vlasta ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Calcipotriol; Netherton syndrome; Treatment

Indexed keywords

CALCIPOTRIOL;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; HUMAN; LABORATORY TEST; MALE; NETHERTON DISEASE; REMISSION; SCHOOL CHILD; SIDE EFFECT; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; CALCITRIOL; CHILD; DERMATOLOGIC AGENTS; HAIR; HUMANS; ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL; MALE; OINTMENTS; SYNDROME;

EID: 1942473015     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Sprecher E, Chavanas S, DiGiovanna JJ, Amin S, Nielsen K, Prendiville JS, Silverman R, Esterly NB, Spraker MK, Guelig E, de Luna ML, Williams ML, Buehler B, Siegfried EC, Van Maldergem L, Pfendner E, Bale SJ, Uitto J, Hovnanian A, Richard G. The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. J Invest Dermatol 2001; 117: 179-87.
2. Stryk S, Siegfried EC, Knutsen AP. Selective antibody deficiency to bacterial polysaccharide antigens in patients with Netherton syndrome. Periatr Dermatol 1999; 16: 19-22.
3. Lucker GPH, van de Kerkhof PCM, van Dijk M R, Steijlen PM. Effect of topical calcipotriol on congenital ichthyosis. Br J Dermatol 1994; 131: 546-50.
4. Kragballe K, Steijlen P M, Ibsen H H, van de Kerkhof PC, Esmann J, Sorensen LH, Axelsen MB. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of randomized, double-blind, vehicle controlled, right/left comparative study. Arch Dermatol 1995; 131: 556-60.
5. Aubin F, Humbert P. Vitamin D in dermatology. Retinoids 1998; 14: 42-6.
6. Lucker GPH, Steijlen PM, Suykerbuyk EJA, Kragballe K, Brandrup F, Van de Kerkhof PC. Flow-cytometric investigation of epidermal cell characteristics in monogenic disorders of keratinization and their modulation by topical calcipotriol treatment. Acta Derm Venereol (Stockh) 1996; 76: 97-101.
7. Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafe JL, Wilkinson J, Taieb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A. Mutations in SPINK 5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000; 25: 141-2.
8. Allen A, Siegfried E, Silverman R, Williams ML, Elias PM, Szabo SK, Korman NJ. Significant absorption of topical tacrolimus in 3 Patients with Netherton syndrome. Arch Dermatol 2001; 137: 747-50.
9. Happle R, van de Kerkhof PC, Traupe H. Retinoids in disorders of keratinization: their use in adults. Dermatologica 1987; 175: 107-24.
10. Hausser I, Anton-Lamprecht I, Hartschuh W, Petzoldt D. Netherton's syndrome: ultrastructure of the active lesion under retinoid therapy. Arch Dermatol Res 1989; 281: 165-72.
11. Braun RP, Ramelet AA. Failure of cyclosporine in Netherton's syndrome. Dermatology 1997; 195: 75.
12. Manabe M, Yoshiike T, Negi M, Ogawa H. Successful therapy of ichthyosis linearis circumflexa with PUVA. J Am Acad Dermatol 1983; 8: 905-7.
13. Suga Y, Tsuboi R, Hoshimoto Y. A cose of ichthyosis linearis circumflexa successfully treated with topical tacrolimus. J Am Acad Dermatol 2000; 42: 520-2.
14. Fartassch M, Williams ML, Elias PM. Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome. Arch Dermatol 1999; 135: 823-32.
15. Chiaretti A, Schembri Wismayer D, Tortorolo L, Piastra M, Polidori G. Salicylate intoxication using a skin ointment. Acta Pediatr 1997; 86: 330-1.
16. Allen DM, Esterly NB. Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. Arch Dermatol 2002; 138: 1259-60.